Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival.

Marissa SherwoodSeth ClimansRonald RamosNormand J LaperriereAndrew F GaoBarbara-Ann MillarDavid B ShultzDerek S TsangWarren P Mason

Published in: Neuro-oncology practice (2022)

Twenty years of adult medulloblastoma treatment was reviewed. Initial chemotherapy patients, most of whom were high risk, trended towards worse survival, but this was nonsignificant. The ideal timing and choice of chemotherapy for adult medulloblastoma is unknown-challenges of administering chemotherapy following photon craniospinal irradiation may have prevented it from becoming routine.

Keyphrases

locally advanced
ejection fraction
end stage renal disease
newly diagnosed
prognostic factors
combination therapy
childhood cancer
radiation therapy
young adults
patient reported outcomes
peritoneal dialysis
living cells
radiation induced
fluorescent probe